These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15579099)

  • 21. The NMR structure of the nucleocapsid protein from the mouse mammary tumor virus reveals unusual folding of the C-terminal zinc knuckle.
    Klein DJ; Johnson PE; Zollars ES; De Guzman RN; Summers MF
    Biochemistry; 2000 Feb; 39(7):1604-12. PubMed ID: 10677209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site.
    Dostálková A; Kaufman F; Křížová I; Kultová A; Strohalmová K; Hadravová R; Ruml T; Rumlová M
    J Virol; 2018 May; 92(10):. PubMed ID: 29491167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.
    Rice WG; Schaeffer CA; Harten B; Villinger F; South TL; Summers MF; Henderson LE; Bess JW; Arthur LO; McDougal JS
    Nature; 1993 Feb; 361(6411):473-5. PubMed ID: 8429889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of retrovirial replication: inactivation of murine leukemia virus by compounds reacting with the zinc finger in the viral nucleocapsid protein.
    Rein A; Ott DE; Mirro J; Arthur LO; Rice WG; Henderson LE
    Leukemia; 1997 Apr; 11 Suppl 3():106-8. PubMed ID: 9209313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
    Mori M; Kovalenko L; Lyonnais S; Antaki D; Torbett BE; Botta M; Mirambeau G; Mély Y
    Curr Top Microbiol Immunol; 2015; 389():53-92. PubMed ID: 25749978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo.
    Zhang WH; Hwang CK; Hu WS; Gorelick RJ; Pathak VK
    J Virol; 2002 Aug; 76(15):7473-84. PubMed ID: 12097560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function.
    Williams MC; Gorelick RJ; Musier-Forsyth K
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8614-9. PubMed ID: 12084921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.
    Topol IA; McGrath C; Chertova E; Dasenbrock C; Lacourse WR; Eissenstat MA; Burt SK; Henderson LE; Casas-Finet JR
    Protein Sci; 2001 Jul; 10(7):1434-45. PubMed ID: 11420445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.
    Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E
    J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1H NMR structure and biological studies of the His23-->Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity.
    Déméné H; Dong CZ; Ottmann M; Rouyez MC; Jullian N; Morellet N; Mely Y; Darlix JL; Fournié-Zaluski MC; Saragosti S
    Biochemistry; 1994 Oct; 33(39):11707-16. PubMed ID: 7918387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The single-finger nucleocapsid protein of moloney murine leukemia virus binds and destabilizes the TAR sequences of HIV-1 but does not promote efficiently their annealing.
    Egelé C; Piémont E; Didier P; Ficheux D; Roques B; Darlix JL; de Rocquigny H; Mély Y
    Biochemistry; 2007 Dec; 46(50):14650-62. PubMed ID: 18027912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo.
    Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO
    Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis.
    Beltz H; Clauss C; Piémont E; Ficheux D; Gorelick RJ; Roques B; Gabus C; Darlix JL; de Rocquigny H; Mély Y
    J Mol Biol; 2005 May; 348(5):1113-26. PubMed ID: 15854648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of immature and mature genomic RNA dimers in wild-type and protease-inactive HIV-1: differential roles of the Gag polyprotein, nucleocapsid proteins NCp15, NCp9, NCp7, and the dimerization initiation site.
    Jalalirad M; Laughrea M
    Virology; 2010 Nov; 407(2):225-36. PubMed ID: 20828778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors.
    Goel A; Mazur SJ; Fattah RJ; Hartman TL; Turpin JA; Huang M; Rice WG; Appella E; Inman JK
    Bioorg Med Chem Lett; 2002 Mar; 12(5):767-70. PubMed ID: 11858998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase.
    Drummond JE; Mounts P; Gorelick RJ; Casas-Finet JR; Bosche WJ; Henderson LE; Waters DJ; Arthur LO
    AIDS Res Hum Retroviruses; 1997 May; 13(7):533-43. PubMed ID: 9135871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-resolution solution NMR structure of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein.
    Kodera Y; Sato K; Tsukahara T; Komatsu H; Maeda T; Kohno T
    Biochemistry; 1998 Dec; 37(51):17704-13. PubMed ID: 9922136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.